Skip to content

The use of a bedside radar device in cystic fibrosis to detect changes in breathing rate during respiratory exacerbation

Continuous contactless respiratory monitoring in cystic fibrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN91138792
Enrollment
8
Registered
2023-05-15
Start date
2022-07-19
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detection of change in respiratory rate in adult patients with cystic fibrosis during inpatient treatment for a pulmonary exacerbation. Respiratory

Interventions

Following study consent, participants will have respiratory rate and related respiratory metrics (including respiratory rate variability, duration of inhalation and exhalation, ratio between respirati

Sponsors

Royal Papworth NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of Cystic Fibrosis and confirmed by genetic testing 2. Age >= 18 years of age at time of consent 3. Able to provide written informed consent 4. Admitted to Royal Papworth Hospital to receive treatment for a pulmonary exacerbation 5. Already using the Project Breathe remote monitoring kit

Exclusion criteria

Exclusion criteria: 1. Patients unable to provide written informed consent 2. Lung transplant recipients

Design outcomes

Primary

MeasureTime frame
Change in mean respiration rate (breaths per minute) during admission day 1 to day 14. The ward nurses will measure respiration rate by counting how many times the participants chest rises in a minute. This information will then be documented in the medical notes.

Secondary

MeasureTime frame
Change in respiratory rate variability using breaths per minute over day 1 to 14. The ward nurses will measure respiration rate by counting how many times the participants chest rises in a minute. This information will then be documented in the medical notes.

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026